In Vivo Assessments of Mucus Dynamics in the Rat Lung Using a Gd-Cy5.5-Bilabeled Contrast Agent for Magnetic Resonance and Optical Imaging

被引:5
作者
Ble, Francois-Xavier [1 ,2 ,3 ]
Schmidt, Philipp [1 ]
Cannet, Catherine [1 ]
Kneuer, Rainer [1 ]
Karmouty-Quintana, Harry [1 ,4 ]
Bergmann, Reinhard
Coote, Kevin [5 ]
Danahay, Henry [5 ]
Zurbruegg, Stefan [1 ]
Gremlich, Hans-Ulrich [1 ]
Beckmann, Nicolau [1 ]
机构
[1] Novartis Inst BioMed Res, Global Imaging Grp, CH-4056 Basel, Switzerland
[2] Novartis Inst BioMed Res, Resp Dis Grp, CH-4056 Basel, Switzerland
[3] Toronto Ctr Phenogenom, Mouse Imaging Ctr, Toronto, ON, Canada
[4] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada
[5] Novartis Inst BioMed Res, Resp Dis Grp, Horsham, W Sussex, England
关键词
lung; MRI; mucociliary clearance; mucus; optical imaging; MUCOCILIARY CLEARANCE; CYSTIC-FIBROSIS; INSOLUBLE PARTICLES; MUCIN SECRETION; AIRWAY SURFACE; TRACHEAL; CHALLENGE; TRANSPORT; VELOCITY; MODELS;
D O I
10.1002/mrm.22130
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Dysfunctions in mucociliary clearance are associated with the accelerated loss of lung function in several respiratory diseases. Approaches enabling the in vivo visualization of mucus dynamics in rodents at high resolution and sensitivity would be beneficial for experimental lung research. We describe the synthesis and characterization of two bilabeled amino dextran-based probes binding specifically to mucin. Labeling of secreted mucus and of mucin in goblet cells in the lungs of lipopolysaccharide-challenged rats has been demonstrated in vivo with near-infrared fluorescence and MRI and confirmed by histology. The effects of uridine triphosphate were then studied in lipopolysaccharide-challenged rats by simultaneously administering the imaging probe and the compound. The data suggest that uridine triphosphate increased the mucociliary clearance, but at the same time induced a release of mucin from goblet cells, thus not contributing to the overall reduction of mucus in the lung. The approach outlined here enables one to derive information on mucus clearance, as well as secretion. Such a global view on mucus dynamics may prove invaluable when testing new pharmacological agents aimed at improving mucociliary clearance. Magn Reson Med 62:1164-1174, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:1164 / 1174
页数:11
相关论文
共 41 条
  • [1] Mucociliary clearance of insoluble particles from the tracheobronchial airways of the human lung
    Asgharian, B
    Hofmann, W
    Miller, FJ
    [J]. JOURNAL OF AEROSOL SCIENCE, 2001, 32 (06) : 817 - 832
  • [2] Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI
    Beckmann, N
    Tigani, B
    Sugar, R
    Jackson, AD
    Jones, G
    Mazzoni, L
    Fozard, JR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2002, 283 (01) : L22 - L30
  • [3] Beckmann N, 2001, MAGNET RESON MED, V45, P88, DOI 10.1002/1522-2594(200101)45:1<88::AID-MRM1013>3.0.CO
  • [4] 2-N
  • [5] Mucociliary clearance is enhanced in rat models of cigarette smoke and lipopolysaccharide-induced lung disease
    Coote, K
    Nicholls, A
    Atherton, HC
    Sugar, R
    Danahay, H
    [J]. EXPERIMENTAL LUNG RESEARCH, 2004, 30 (01) : 59 - 71
  • [6] Membrane capacitance and conductance changes parallel mucin secretion in the human airway epithelium
    Danahay, H
    Atherton, HC
    Jackson, AD
    Kreindler, JL
    Poll, CT
    Bridges, RJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2006, 290 (03) : L558 - L569
  • [7] Danahay Henry, 2005, Current Drug Targets - Inflammation and Allergy, V4, P651, DOI 10.2174/156801005774912851
  • [8] Davis CW, 2002, NOVART FDN SYMP, V248, P113
  • [9] COMPARISON OF TRACHEAL MUCOUS TRANSPORT IN RATS, GUINEA-PIGS, RABBITS, AND DOGS
    FELICETTI, SA
    WOLFF, RK
    MUGGENBURG, BA
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1981, 51 (06) : 1612 - 1617
  • [10] Effects of dextran on tracheal mucociliary velocity in dogs in vivo
    Feng, W
    Nakamura, S
    Sudo, E
    Lee, MM
    Shao, A
    King, M
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 1999, 12 (01) : 35 - 41